Logo image of CON

CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

NYSE:CON - New York Stock Exchange, Inc. - US20603L1026 - Common Stock - Currency: USD

21.97  -0.11 (-0.5%)

After market: 21.97 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CON. CON was compared to 102 industry peers in the Health Care Providers & Services industry. CON has a medium profitability rating, but doesn't score so well on its financial health evaluation. CON has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CON had positive earnings in the past year.
In the past year CON had a positive cash flow from operations.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

CON has a Return On Assets of 5.73%. This is amongst the best in the industry. CON outperforms 82.35% of its industry peers.
With an excellent Return On Equity value of 50.96%, CON belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.26%, CON belongs to the best of the industry, outperforming 86.27% of the companies in the same industry.
CON had an Average Return On Invested Capital over the past 3 years of 23.70%. This is significantly above the industry average of 9.62%.
The 3 year average ROIC (23.70%) for CON is well above the current ROIC(11.26%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.73%
ROE 50.96%
ROIC 11.26%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

CON has a Profit Margin of 8.09%. This is amongst the best in the industry. CON outperforms 90.20% of its industry peers.
In the last couple of years the Profit Margin of CON has declined.
CON has a better Operating Margin (16.01%) than 90.20% of its industry peers.
CON's Operating Margin has declined in the last couple of years.
CON's Gross Margin of 27.98% is in line compared to the rest of the industry. CON outperforms 55.88% of its industry peers.
In the last couple of years the Gross Margin of CON has declined.
Industry RankSector Rank
OM 16.01%
PM (TTM) 8.09%
GM 27.98%
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CON is creating value.
CON has more shares outstanding than it did 1 year ago.
CON has a worse debt/assets ratio than last year.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CON has an Altman-Z score of 1.82. This is not the best score and indicates that CON is in the grey zone with still only limited risk for bankruptcy at the moment.
CON has a Altman-Z score (1.82) which is in line with its industry peers.
The Debt to FCF ratio of CON is 9.13, which is on the high side as it means it would take CON, 9.13 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.13, CON perfoms like the industry average, outperforming 50.98% of the companies in the same industry.
CON has a Debt/Equity ratio of 5.27. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.27, CON is doing worse than 81.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.27
Debt/FCF 9.13
Altman-Z 1.82
ROIC/WACC1.39
WACC8.11%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B

2.3 Liquidity

A Current Ratio of 1.10 indicates that CON should not have too much problems paying its short term obligations.
With a Current ratio value of 1.10, CON is not doing good in the industry: 67.65% of the companies in the same industry are doing better.
CON has a Quick Ratio of 1.10. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CON (1.10) is worse than 60.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.72% over the past year.
The Earnings Per Share has been decreasing by -3.99% on average over the past years.
CON shows a small growth in Revenue. In the last year, the Revenue has grown by 3.38%.
The Revenue has been growing slightly by 3.14% on average over the past years.
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-20.56%
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%7.09%

3.2 Future

The Earnings Per Share is expected to grow by 8.29% on average over the next years. This is quite good.
Based on estimates for the next years, CON will show a quite strong growth in Revenue. The Revenue will grow by 8.47% on average per year.
EPS Next Y-4.81%
EPS Next 2Y6.02%
EPS Next 3Y8.29%
EPS Next 5YN/A
Revenue Next Year11.99%
Revenue Next 2Y9.64%
Revenue Next 3Y8.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.15 indicates a correct valuation of CON.
Based on the Price/Earnings ratio, CON is valued a bit cheaper than the industry average as 74.51% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.59. CON is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 13.88, CON is valued correctly.
77.45% of the companies in the same industry are more expensive than CON, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CON to the average of the S&P500 Index (22.39), we can say CON is valued slightly cheaper.
Industry RankSector Rank
PE 16.15
Fwd PE 13.88
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CON indicates a somewhat cheap valuation: CON is cheaper than 64.71% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CON indicates a somewhat cheap valuation: CON is cheaper than 73.53% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.74
EV/EBITDA 11.77
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

CON has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.02%
EPS Next 3Y8.29%

3

5. Dividend

5.1 Amount

CON has a Yearly Dividend Yield of 1.15%.
Compared to an average industry Dividend Yield of 2.46, CON pays a better dividend. On top of this CON pays more dividend than 85.29% of the companies listed in the same industry.
With a Dividend Yield of 1.15, CON pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.15%

5.2 History

CON is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

5.09% of the earnings are spent on dividend by CON. This is a low number and sustainable payout ratio.
DP5.09%
EPS Next 2Y6.02%
EPS Next 3Y8.29%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 100M 200M 300M 400M 500M
CON Dividend Payout.CON Dividend Payout, showing the Payout Ratio.CON Dividend Payout.PayoutRetained Earnings

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (6/10/2025, 8:04:00 PM)

After market: 21.97 0 (0%)

21.97

-0.11 (-0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-28 2025-07-28
Inst Owners85.81%
Inst Owner Change-0.36%
Ins Owners6.63%
Ins Owner Change0%
Market Cap2.82B
Analysts81.67
Price Target28.27 (28.68%)
Short Float %1.68%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 1.15%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP5.09%
Div Incr Years0
Div Non Decr Years1
Ex-Date05-20 2025-05-20 (0.0625)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.91%
Min EPS beat(2)0.58%
Max EPS beat(2)1.24%
EPS beat(4)4
Avg EPS beat(4)1.51%
Min EPS beat(4)0.58%
Max EPS beat(4)3.19%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)-0.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.52%
PT rev (3m)1.04%
EPS NQ rev (1m)-0.98%
EPS NQ rev (3m)4.03%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)2.94%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)2.49%
Revenue NY rev (1m)0.94%
Revenue NY rev (3m)3.67%
Valuation
Industry RankSector Rank
PE 16.15
Fwd PE 13.88
P/S 1.46
P/FCF 15.74
P/OCF 11.65
P/B 9.17
P/tB N/A
EV/EBITDA 11.77
EPS(TTM)1.36
EY6.19%
EPS(NY)1.58
Fwd EY7.2%
FCF(TTM)1.4
FCFY6.35%
OCF(TTM)1.89
OCFY8.59%
SpS15.08
BVpS2.4
TBVpS-10.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 50.96%
ROCE 12.85%
ROIC 11.26%
ROICexc 11.51%
ROICexgc 40.95%
OM 16.01%
PM (TTM) 8.09%
GM 27.98%
FCFM 9.25%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
ROICexc(3y)24.7%
ROICexc(5y)N/A
ROICexgc(3y)89.31%
ROICexgc(5y)N/A
ROCE(3y)27.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
F-Score4
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 5.27
Debt/FCF 9.13
Debt/EBITDA 4.32
Cap/Depr 96.2%
Cap/Sales 3.25%
Interest Coverage 3.98
Cash Conversion 64.49%
Profit Quality 114.33%
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 1.82
F-Score4
WACC8.11%
ROIC/WACC1.39
Cap/Depr(3y)84.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)N/A
Profit Quality(3y)135.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.72%
EPS 3Y-3.99%
EPS 5YN/A
EPS Q2Q%-20.56%
EPS Next Y-4.81%
EPS Next 2Y6.02%
EPS Next 3Y8.29%
EPS Next 5YN/A
Revenue 1Y (TTM)3.38%
Revenue growth 3Y3.14%
Revenue growth 5YN/A
Sales Q2Q%7.09%
Revenue Next Year11.99%
Revenue Next 2Y9.64%
Revenue Next 3Y8.47%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3Y-0.08%
EBIT growth 5YN/A
EBIT Next Year37.41%
EBIT Next 3Y18.37%
EBIT Next 5YN/A
FCF growth 1Y21.47%
FCF growth 3Y-3.19%
FCF growth 5YN/A
OCF growth 1Y17.23%
OCF growth 3Y-1.87%
OCF growth 5YN/A